Aspen Pharmacare – is the market rating the share price too low? Read the long-term Mergence houseview by Portfolio Manager Izak van Niekerk.

‘We want to be number 1 by far’: Prosus looks to benefit from Europe’s hunger for tech champs
Commenting on this week’s announcement by Prosus that it is willing to offer an near 50% premium for the Dutch